공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

약물감시(Pharmacovigilance) 및 의약품 안전성 소프트웨어 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 391332
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


약물감시(Pharmacovigilance) 및 의약품 안전성 소프트웨어 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 약물감시(PV) 및 의약품 안전성 소프트웨어 시장은 약물 부작용(ADR) 발생률 상승, 출시 의약품 증가, 수탁 연구기관 및 수탁 제조기관 등 아웃소싱 기업의 약물감시 소프트웨어 도입 증가, 여러가지 약제 병용 증가와 의약품 안전 규제에 관한 정책 등이 시장 성장 주요인입니다.

세계의 약물감시(Pharmacovigilance) 및 의약품 안전성(Drug Safety) 소프트웨어 시장을 조사했으며, 시장 개요, 기능·전개 유형·최종사용자·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 전제조건
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 니코틴 의존자수
    • 흡연 위험성에 대한 의식
    • 담배 제품 광고 금지
  • 시장 성장 저해요인
    • 약물 부작용
  • Five Forces 분석
    • 구매자의 협상력
    • 공급기업의 협상력
    • 신규 진출기업의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 시장 세분화

  • 기능별
    • 부작용 보고 소프트웨어
    • 의약품 안전성 관리 소프트웨어
    • 문제 추적 소프트웨어
    • 완전 통합 소프트웨어
  • 전개 유형별
    • 온프레미스
    • 온디맨드/클라우드 기반(SaaS)
  • 최종사용자별
    • 제약 기업 및 바이오테크놀러지 기업
    • 임상시험수탁기관(CRO)
    • 비즈니스 프로세스 아웃소싱(BPO) 기업
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 구도

  • 기업 개요
    • Ab Cube
    • ArisGlobal
    • Ennov Solutions, Inc.
    • Extedo GmbH
    • Online Business Applications, Inc.
    • Oracle Corporation
    • Sarjen Systems Pvt Ltd
    • Sparta Systems, Inc.
    • Umbra Global LLC
    • United BioSource Corporation

제7장 시장 기회 및 향후 동향

LSH 19.07.01

The pharmacovigilance and drug safety software market is expected to register a high growth due to the increasing incidence of adverse drug reactions (ADRs) that is the major driving factor for the growth of the pharmacovigilance and drug safety software market.

According to the National Institute of Health, approximately 5% of all hospital admissions in Europe are caused by ADRs. Furthermore, factors, like the increasing adoption of pharmacovigilance and drug safety software by the outsourcing companies involved in contract research and contract manufacturing, owing to the rising number of drugs on the market, and an upward trend in polypharmacy, and government policies pertaining to drug safety regulations are driving the growth of the market.

However, lack of awareness and knowledge about pharmacovigilance and ADRs among healthcare professionals, and adverse effects of drugs are found restraining the growth of the pharmacovigilance and drug safety software market.

Key Market Trends

Drug Safety Audits Software is Expected to Hold a High Market Share in the Functionality Segment

By functionality, the pharmacovigilance and drug safety software market has been segmented into adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software.

Based on the recent trends, the high market share of the drug safety audits software segment is attributed to the increasing number of contract research and manufacturing organizations that are making extensive use of drug safety audits software for ensuring compliance with standards set by apex drug regulatory bodies. In addition, the fully integrated software segment is also one of the fastest growing segment in the market.

North America Dominates the Market and Expected to do the Same in the Forecast Period

North America is found dominating the pharmacovigilance and drug safety software market, due to the increasing research expenditure and government initiatives in the region. Adverse drug reactions are one of the major causes of hospitalizations and deaths in the United States, thus, fueling the pharmacovigilance and drug safety software market.

Furthermore, initiatives undertaken by the governments are also propelling the growth of the market in North America. For instance, the Open FDA initiative undertaken by the US government provides access to its database, by open search-based programs, for application developers and scientists. Additionally, the United States initiated another project, called Mini-Sentinel, to promote active surveillance system by providing relevant statistical data in less time.

Competitive Landscape

The companies operating in the pharmacovigilance and drug safety software market are capitalizing on the innovative researches focusing on the development of editing techniques. Key strategies implemented by the market players, including mergers, acquisitions, and strategic collaborations for R&D outsourcing or manufacturing activities, are driving the market growth.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Adverse Drug Reactions (Adrs)
    • 4.2.2 Increasing Adoption Of Pharmacovigilance Software By Outsourcing Companies
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness About Pharmacovigilance
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Functionality
    • 5.1.1 Adverse Event Reporting Software
    • 5.1.2 Drug Safety Audits Software
    • 5.1.3 Issue Tracking Software
    • 5.1.4 Fully Integrated Software
  • 5.2 By Mode of Delivery
    • 5.2.1 On-premise Delivery
    • 5.2.2 On-demand/ Cloud-based (SaaS) Delivery
  • 5.3 By End-Users
    • 5.3.1 Pharmaceutical and Biotechnology Companies
    • 5.3.2 Contract Research Organizations
    • 5.3.3 Business Process Outsourcing Firms
    • 5.3.4 Other Pharmacovigilance Service Providers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ab Cube
    • 6.1.2 ArisGlobal
    • 6.1.3 Ennov Solutions Inc.
    • 6.1.4 Extedo GmbH
    • 6.1.5 Online Business Applications Inc.
    • 6.1.6 Oracle Corporation
    • 6.1.7 Sarjen Systems Pvt Ltd
    • 6.1.8 Sparta Systems Inc.
    • 6.1.9 United BioSource Corporation
    • 6.1.10 Max Application
    • 6.1.11 Veeva Systems
    • 6.1.12 Phase Forward

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q